Abstract
The association of lead with chromatin in cells suggests that deleterious metal effects may in part be mediated through alterations in gene function. To elucidate if and how lead may alter DNA binding of cysteine-rich zinc finger proteins, lead ions were analyzed for their ability to alter the DNA binding mechanism of the Cys2His2 zinc finger protein transcription factor IIIA (TFIIIA). As assayed by DNase I protection, the interaction of TFIIIA with the 50-bp internal control region of the 5S ribosomal gene was partially inhibited by 5 μM lead ions and completely inhibited by 10 to 20 μM lead ions. Preincubation of free TFIIIA with lead resulted in DNA-binding inhibition, whereas preincubation of a TFIIIA/5S RNA complex with lead did not result in DNA-binding inhibition. Because 5S RNA binds TFIIIA zinc fingers, this result is consistent with an inhibition mechanism via lead binding to zinc fingers. The complete loss of DNase I protection on the 5S gene indicates the mechanism of inhibition minimally involves the N-terminal fingers of TFIIIA. Inhibition was not readily reversible and occurred in the presence of an excess of β-mercaptoethanol. Inhibition kinetics were fast, progressing to completion in ∼5 min. Millimolar concentrations of sulfhydryl-specific arsenic ions were not inhibitory for TFIIIA binding. Micromolar concentrations of lead inhibited DNA binding by Sp1, another Cys2His2 finger protein, but not by the nonfinger protein AP2. Inhibition of Cys2His2 zinc finger transcription factors by lead ions at concentrations near those known to have deleterious physiological effects points to new molecular mechanisms for lead toxicity in promoting disease.
Footnotes
- Received March 15, 1999.
- Accepted August 2, 1999.
-
Send reprint requests to: Jay S. Hanas, Ph.D., Department of Biochemistry and Molecular Biology, University of Oklahoma College of Medicine, 800 Research Pkwy., Room 448, Oklahoma City, OK 73104. E-mail: Jay-Hanas{at}ouhsc.edu
-
↵1 Current address: Department of Zoology, Oklahoma State University, 430 Life Sciences West, Stillwater, OK 74074.
-
This work was supported by a grant from the Environmental Protection Agency (R 826273-01-0).
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|